IV Daratumumab versus Subcutaneous Daratumumab

IV Daratumumab versus Subcutaneous Daratumumab
Don Photo

Don
3 years 127 Views
Category:
Description:
Saad Usmani, MD, Chief, Plasma Cell Disorders Program, Hematologic Malignancies, Levine Cancer Institute/Atrium Health, UNC Chapel Hill School of Medicine, compares intravenous daratumumab versus subcutaneous daratumumab.